Blog
931 Articles

Testing the Effect of a Malaria Drug on Standard Treatment
A clinical trial tests whether a malaria drug can make standard chemotherapy for advanced pancreatic cancer more effective.

Understanding a Family’s Risk for Pancreatic Cancer
A tumor registry studies the genetics of pancreatic cancer to determine risk factors for families.

Discovering the Better Drug Treatment After Surgery for Pancreatic Cancer
A clinical trial compares two chemotherapy regimens to see which one is more effective at knocking out remaining cancer cells.

The Link Between Pancreatic Cancer and Diabetes
Dr. Suresh Chari of the Mayo Clinic has spent a good part of his career looking at the relationship between pancreatic cancer and diabetes.

Exploring the Better Treatment for Stable Metastatic Pancreatic Cancer
For patients with stable metastatic pancreatic cancer, a clinical trial compares standard chemotherapy with immunotherapy.

Fighting Pancreatic Cancer in a Petri Dish
Dr. David Tuveson is growing pancreatic cancer tissue called organoids in the lab, to test which drugs will be most effective against a patient’s tumor.

Patients Needed for Clinical Trial/Research Study of Treatment Targeting Immune System
A clinical trial seeks pancreatic cancer patients with the MSI (microsatellite instability) genetic signature, to test an immunotherapy drug.

Low-Dose Continuous Chemotherapy as Part of a New Combination of Drugs
A clinical trial uses a new immunotherapy drug in combination with standard chemotherapy drugs in metronomic therapy to treat metastatic pancreatic cancer.

Personalizing Pancreatic Cancer Treatment
Dr. Mark Ricigliano takes a closer look at the genetics of circulating tumor cells, to personalize pancreatic cancer treatment for the best results.

A Liquid Biopsy for Pancreatic Cancer
Dr. Bert Vogelstein and his team at Johns Hopkins are working with a blood test called a liquid biopsy, which tests cells for mutations related to cancer.